دورية أكاديمية

Development of a new real-time PCR screening kit for HbS and common beta-thalassemia mutations observed in Turkey.

التفاصيل البيبلوغرافية
العنوان: Development of a new real-time PCR screening kit for HbS and common beta-thalassemia mutations observed in Turkey.
المؤلفون: Kan Karaer D; Department of Medical Genetics, Faculty of Medicine, Gazi University, Ankara, Turkey.; Department of Medical Genetics, Dr. Ersin Arslan Research and Training Hospital, Gaziantep, Turkey., Ergün MA; Department of Medical Genetics, Faculty of Medicine, Gazi University, Ankara, Turkey., Ruhi HI; Department of Medical Genetics, Faculty of Medicine, Ankara University, Ankara, Turkey., Öztürk J; Provincial Health Directorate, Ankara, Turkey., Kara H; Provincial Health Directorate, Ankara, Turkey., Reisoğlu Çakmak D; Provincial Health Directorate, Ankara, Turkey., Aydoğmuş T; Provincial Health Directorate, Ankara, Turkey., Perçin EF; Department of Medical Genetics, Faculty of Medicine, Gazi University, Ankara, Turkey.
المصدر: Turkish journal of medical sciences [Turk J Med Sci] 2017 Jun 12; Vol. 47 (3), pp. 973-978. Date of Electronic Publication: 2017 Jun 12.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Scientific and Technical Research Council of Turkey Country of Publication: Turkey NLM ID: 9441758 Publication Model: Electronic Cited Medium: Print ISSN: 1300-0144 (Print) Linking ISSN: 13000144 NLM ISO Abbreviation: Turk J Med Sci Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Ankara : Scientific and Technical Research Council of Turkey, [1994-
مواضيع طبية MeSH: beta-Thalassemia*/diagnosis , beta-Thalassemia*/genetics, Hemoglobin, Sickle/*genetics , Mutation/*genetics , Real-Time Polymerase Chain Reaction/*methods, DNA Mutational Analysis/methods ; Humans ; Reproducibility of Results ; Turkey
مستخلص: Background/aim: IVSI-110 (G>A), IVSI-6 (T>C), IVSII-1 (G>A), IVSII-745 (C>G), IVSI-1 (G>A), and HbS are mutations covering 76% of all the β-globin mutations in the Turkish population. In this study, our aim is to develop a reliable, fast, real-time kit for these mutations using the TaqMan probe method.
Materials and Methods: This study included 100 individuals with beta-thalassemia or sickle cell anemia who had unknown mutations, and 21 controls with known mutations.
Results: We designed a kit containing the IVSI-110 (G>A), IVSI-6 (T>C), IVSII-1 (G>A), IVSII-745 (C>G), IVSI-1 (G>A), and HbS mutations by using the real-time PCR method. One hundred patients were studied with our developed TaqMan real-time PCR kit. Of these patients, 73 (73%) were identified with the beta gene mutation. Among those 73 patients, 16 were homozygous, 54 were heterozygous, and 3 were compound heterozygous.
Conclusion: This reliable kit provided rapid diagnosis including 76% of the β-thalassemia mutations in Turkey.
فهرسة مساهمة: Keywords: Beta-thalassemia; HbS; mutation; β-thalassemia screening kit
المشرفين على المادة: 0 (Hemoglobin, Sickle)
تواريخ الأحداث: Date Created: 20170617 Date Completed: 20190107 Latest Revision: 20190107
رمز التحديث: 20221213
DOI: 10.3906/sag-1606-49
PMID: 28618753
قاعدة البيانات: MEDLINE
الوصف
تدمد:1300-0144
DOI:10.3906/sag-1606-49